Point72 Hong Kong’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,218
| Closed | -$193K | – | 480 |
|
|
2024
Q4 | $193K | Buy |
+2,218
| New | +$193K | 0.01% | 277 |
|
|
2024
Q3 | – | Sell |
-3,339
| Closed | -$360K | – | 467 |
|
|
2024
Q2 | $360K | Buy |
+3,339
| New | +$360K | 0.02% | 265 |
|
|
2022
Q4 | – | Sell |
-5,280
| Closed | -$348K | – | 218 |
|
|
2022
Q3 | $348K | Buy |
5,280
+5,174
| +4,881% | +$341K | 0.01% | 443 |
|
|
2022
Q2 | $5K | Sell |
106
-3,207
| -97% | -$151K | ﹤0.01% | 1278 |
|
|
2022
Q1 | $212K | Buy |
+3,313
| New | +$212K | 0.01% | 470 |
|
|
2021
Q4 | – | Sell |
-786
| Closed | -$81K | – | 1367 |
|
|
2021
Q3 | $81K | Buy |
+786
| New | +$81K | ﹤0.01% | 797 |
|
|
2020
Q4 | – | Sell |
-506
| Closed | -$47K | – | 1275 |
|
|
2020
Q3 | $47K | Buy |
506
+435
| +613% | +$40.4K | 0.01% | 684 |
|
|
2020
Q2 | $6K | Sell |
71
-352
| -83% | -$29.7K | ﹤0.01% | 1018 |
|
|
2020
Q1 | $25K | Buy |
+423
| New | +$25K | 0.01% | 493 |
|
|
2019
Q4 | – | Sell |
-1,384
| Closed | -$102K | – | 1157 |
|
|
2019
Q3 | $102K | Buy |
+1,384
| New | +$102K | 0.03% | 447 |
|
|
2018
Q4 | – | Sell |
-436
| Closed | -$34K | – | 900 |
|
|
2018
Q3 | $34K | Buy |
+436
| New | +$34K | 0.01% | 517 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 907 |
|
|
2017
Q4 | $0 | Sell |
1
-366
| -100% | – | ﹤0.01% | 857 |
|
|
2017
Q3 | $26K | Buy |
+367
| New | +$26K | 0.02% | 348 |
|
|
2017
Q2 | – | Sell |
-1,886
| Closed | -$75K | – | 822 |
|
|
2017
Q1 | $75K | Buy |
+1,886
| New | +$75K | 0.1% | 161 |
|